We don’t want to miss out on life’s most precious moments.
The PRESENCE Study is currently looking for participants to evaluate a new investigational treatment to improve memory and thinking in people with dementia associated with Parkinson’s disease or Dementia with Lewy Bodies (DLB).
You may qualify if you:
- Are between the ages of 40 and 85
- Are experiencing a change in memory and thinking
- Have an existing diagnosis of Parkinson’s disease or Dementia with Lewy Bodies (DLB)
- Have a study partner willing to attend clinic appointments with the study participant
- All study-related care will be provided at no cost. Health insurance is not needed
About Dementia Associated with Parkinson’s Disease (PDD)
Dementia associated with Parkinson’s disease is diagnosed if symptoms of dementia are present in persons with Parkinson’s disease.
Up to 80% of patients with PD will develop dementia usually 10-15 years after diagnosis. Typically, people with Parkinson’s disease that develop symptoms of dementia, will do so around 10-15 years after their initial Parkinson’s diagnosis.
Dementia has a worse impact on those with Parkinson’s disease as compared to those with Alzheimer’s disease because of the combination of motor and cognitive issues.
The PRESENCE Study is evaluating an investigational medication with the goal of improving memory and thinking in those suffering from dementia associated with Parkinson’s disease.
source: American Journal of Alzheimer’s Disease & Other Dementias® 2016, Vol. 31(7) 585-594